May 14, 2024 Accessibility and Affordability Working Group Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
TREATMENT AND CURES ACCESSIBILITY AND AFFORDABILITY WORKING GROUP
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: May 14, 2024
Time: 1:00 p.m. to 2:30 p.m.

Location: 601 Gateway Blvd., Suite 400
South San Francisco, CA 94080

This meeting of the Accessibility and Affordability Working Group will be conducted by teleconference only. None of the locations from which members will participate will be open to the public. Members of the public who wish to listen to the meeting may do so via telephone by dialing the number listed below. Members of the public who wish to comment during the meeting may do so by telephone or email, as described below.

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:

• Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
• Once we call your name you will have 3-minutes to make your public comment; please remember to be respectful of the time limit.
• Written comment may be sent to the following email address: mdelatorre@cirm.ca.gov.

YouTube:

https://www.youtube.com/cirmtv

 

Dial-In information:

Dial in number: (669) 900 6833

Meeting ID: 867 6563 9611

Passcode: 148426

 

Open Session

1. Call to Order

2. Roll Call

 Discussion Items

3. Update on the Patient Support Program

4. Update on the Community Care Centers of Excellence (CCCE) RFA  
   • Presentation

5. Update on the Strategic Allocation Framework (SAF)
   • Briefing Memo
   • Presentation

6. Closed Session:

Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to BLA status for CLIN portfolio. (Health & Safety Code 125290.30(f) (3) (B) and (C)).

7. Public comment
8. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Marivel De La Torre at the California Institute for Regenerative Medicine at (415) 769-8730 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens’ Oversight Committee meeting may be referred to Marivel De La Torre at the California Institute for Regenerative Medicine at mdelatorre@cirm.ca.gov or (415) 769-8730.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

 

---